Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Medical Devices & Consumables > Global Humanized Immune System (HIS) Models Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Global Humanized Immune System (HIS) Models Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Medical Devices & Consumables

Published: 2026-03-12

Pages: 97 Pages

Report ld: 6240092

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global Humanized Immune System (HIS) Models market size was US$ 268 million in 2025 and is forecast to reach a readjusted size of US$ 433 million by 2032 with a CAGR of 7.2% during the forecast period 2026-2032.

Humanized Immune System (HIS) models are animal models, typically immunodeficient mice, engrafted with human immune cells or hematopoietic stem cells to reconstitute a functional human immune system. These models allow the study of human-specific immune responses and are widely used in research on infectious diseases, cancer immunology, autoimmune disorders, and immunotherapy development. HIS models provide a crucial platform for preclinical testing and translational medicine.

Humanized Immune System (HIS) Models Market Size(US$)

M= millions and B=billions

In 2025, the North America Humanized Immune System (HIS) Models market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.

The global key players of Humanized Immune System (HIS) Models include Charles River, Taconic Biosciences, Inotiv, Jackson Laboratory, Janvier, Crown Bioscience, GenOway, Oncodesign Services, Champions Oncology, Miltenyi Biotec, among others. In 2025, the top five players accounted for approximately % of global market revenue.

In terms of revenue, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.

The global Humanized Immune System (HIS) Models market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.

Market Segmentation
By Company: 
    Charles River
    Taconic Biosciences
    Inotiv
    Jackson Laboratory
    Janvier
    Crown Bioscience
    GenOway
    Oncodesign Services
    Champions Oncology
    Miltenyi Biotec
    BioDuro
    GemPharmatech
    Shanghai Model Organisms
    Biocytogen

Segment by Type
    Mouse
    Rat

Segment by Application
    Research Institutes
    Pharmaceutical Companies

By Region 
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
    North America
    Europe
    China
    Japan

(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of Humanized Immune System (HIS) Models market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets 
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities 
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Humanized Immune System (HIS) Models value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Market by Type
        1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
        1.2.2 Mouse
        1.2.3 Rat
    1.3 Market by Application
        1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
        1.3.2 Research Institutes
        1.3.3 Pharmaceutical Companies
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Global Growth Trends
    2.1 Global Humanized Immune System (HIS) Models Market Perspective (2021-2032)
    2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
    2.3 Global Humanized Immune System (HIS) Models Market Share by Revenue, by Region (2021-2026)
    2.4 Global Humanized Immune System (HIS) Models Revenue Forecast by Region (2027-2032)
    2.5 Major Regions and Emerging Markets Analysis
        2.5.1 North America Humanized Immune System (HIS) Models Market Size and Prospective (2021-2032)
        2.5.2 Europe Humanized Immune System (HIS) Models Market Size and Prospective (2021-2032)
        2.5.3 China Humanized Immune System (HIS) Models Market Size and Prospective (2021-2032)
        2.5.4 Japan Humanized Immune System (HIS) Models Market Size and Prospective (2021-2032)

3 Breakdown Data by Type
    3.1 Global Humanized Immune System (HIS) Models Historical Market Size by Type (2021-2026)
    3.2 Global Humanized Immune System (HIS) Models Forecasted Market Size by Type (2027-2032)
    3.3 Representative Players for Different Types of Humanized Immune System (HIS) Models

4 Breakdown Data by Application
    4.1 Global Humanized Immune System (HIS) Models Historical Market Size by Application (2021-2026)
    4.2 Global Humanized Immune System (HIS) Models Forecasted Market Size by Application (2027-2032)
    4.3 New Sources of Growth in Humanized Immune System (HIS) Models Applications

5 Competitive Landscape by Players
    5.1 Global Top Players by Revenue
        5.1.1 Global Top Humanized Immune System (HIS) Models Players by Revenue (2021-2026)
        5.1.2 Global Humanized Immune System (HIS) Models Market Share by Revenue, by Players (2021-2026)
    5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    5.3 Players Covered: Ranking by Humanized Immune System (HIS) Models Revenue
    5.4 Global Humanized Immune System (HIS) Models Market Concentration Analysis
        5.4.1 Global Humanized Immune System (HIS) Models Market Concentration Ratio (CR5 and HHI)
        5.4.2 Global Top 10 and Top 5 Companies by Humanized Immune System (HIS) Models Revenue in 2025
    5.5 Global Key Players of Humanized Immune System (HIS) Models Head Offices and Areas Served
    5.6 Global Key Players of Humanized Immune System (HIS) Models, Product and Application
    5.7 Global Key Players of Humanized Immune System (HIS) Models, Date of Entry into This Industry
    5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis
    6.1 North America Market: Players, Segments, Downstream and Major Customers
        6.1.1 North America Humanized Immune System (HIS) Models Revenue by Company (2021-2026)
        6.1.2 North America Market Size by Type
            6.1.2.1 North America Humanized Immune System (HIS) Models Market Size by Type (2021-2026)
            6.1.2.2 North America Humanized Immune System (HIS) Models Market Share by Type (2021-2026)
        6.1.3 North America Market Size by Application
            6.1.3.1 North America Humanized Immune System (HIS) Models Market Size by Application (2021-2026)
            6.1.3.2 North America Humanized Immune System (HIS) Models Market Share by Application (2021-2026)
        6.1.4 North America Humanized Immune System (HIS) Models Major Customers
        6.1.5 North America Market Trends and Opportunities
    6.2 Europe Market: Players, Segments, Downstream and Major Customers
        6.2.1 Europe Humanized Immune System (HIS) Models Revenue by Company (2021-2026)
        6.2.2 Europe Market Size by Type
            6.2.2.1 Europe Humanized Immune System (HIS) Models Market Size by Type (2021-2026)
            6.2.2.2 Europe Humanized Immune System (HIS) Models Market Share by Type (2021-2026)
        6.2.3 Europe Market Size by Application
            6.2.3.1 Europe Humanized Immune System (HIS) Models Market Size by Application (2021-2026)
            6.2.3.2 Europe Humanized Immune System (HIS) Models Market Share by Application (2021-2026)
        6.2.4 Europe Humanized Immune System (HIS) Models Major Customers
        6.2.5 Europe Market Trends and Opportunities
    6.3 China Market: Players, Segments, Downstream and Major Customers
        6.3.1 China Humanized Immune System (HIS) Models Revenue by Company (2021-2026)
        6.3.2 China Market Size by Type
            6.3.2.1 China Humanized Immune System (HIS) Models Market Size by Type (2021-2026)
            6.3.2.2 China Humanized Immune System (HIS) Models Market Share by Type (2021-2026)
        6.3.3 China Market Size by Application
            6.3.3.1 China Humanized Immune System (HIS) Models Market Size by Application (2021-2026)
            6.3.3.2 China Humanized Immune System (HIS) Models Market Share by Application (2021-2026)
        6.3.4 China Humanized Immune System (HIS) Models Major Customers
        6.3.5 China Market Trends and Opportunities
    6.4 Japan Market: Players, Segments, Downstream and Major Customers
        6.4.1 Japan Humanized Immune System (HIS) Models Revenue by Company (2021-2026)
        6.4.2 Japan Market Size by Type
            6.4.2.1 Japan Humanized Immune System (HIS) Models Market Size by Type (2021-2026)
            6.4.2.2 Japan Humanized Immune System (HIS) Models Market Share by Type (2021-2026)
        6.4.3 Japan Market Size by Application
            6.4.3.1 Japan Humanized Immune System (HIS) Models Market Size by Application (2021-2026)
            6.4.3.2 Japan Humanized Immune System (HIS) Models Market Share by Application (2021-2026)
        6.4.4 Japan Humanized Immune System (HIS) Models Major Customers
        6.4.5 Japan Market Trends and Opportunities

7 Key Player Profiles
    7.1 Charles River
        7.1.1 Charles River Company Details
        7.1.2 Charles River Business Overview
        7.1.3 Charles River Humanized Immune System (HIS) Models Introduction
        7.1.4 Charles River Revenue in Humanized Immune System (HIS) Models Business (2021-2026)
        7.1.5 Charles River Recent Development
    7.2 Taconic Biosciences
        7.2.1 Taconic Biosciences Company Details
        7.2.2 Taconic Biosciences Business Overview
        7.2.3 Taconic Biosciences Humanized Immune System (HIS) Models Introduction
        7.2.4 Taconic Biosciences Revenue in Humanized Immune System (HIS) Models Business (2021-2026)
        7.2.5 Taconic Biosciences Recent Development
    7.3 Inotiv
        7.3.1 Inotiv Company Details
        7.3.2 Inotiv Business Overview
        7.3.3 Inotiv Humanized Immune System (HIS) Models Introduction
        7.3.4 Inotiv Revenue in Humanized Immune System (HIS) Models Business (2021-2026)
        7.3.5 Inotiv Recent Development
    7.4 Jackson Laboratory
        7.4.1 Jackson Laboratory Company Details
        7.4.2 Jackson Laboratory Business Overview
        7.4.3 Jackson Laboratory Humanized Immune System (HIS) Models Introduction
        7.4.4 Jackson Laboratory Revenue in Humanized Immune System (HIS) Models Business (2021-2026)
        7.4.5 Jackson Laboratory Recent Development
    7.5 Janvier
        7.5.1 Janvier Company Details
        7.5.2 Janvier Business Overview
        7.5.3 Janvier Humanized Immune System (HIS) Models Introduction
        7.5.4 Janvier Revenue in Humanized Immune System (HIS) Models Business (2021-2026)
        7.5.5 Janvier Recent Development
    7.6 Crown Bioscience
        7.6.1 Crown Bioscience Company Details
        7.6.2 Crown Bioscience Business Overview
        7.6.3 Crown Bioscience Humanized Immune System (HIS) Models Introduction
        7.6.4 Crown Bioscience Revenue in Humanized Immune System (HIS) Models Business (2021-2026)
        7.6.5 Crown Bioscience Recent Development
    7.7 GenOway
        7.7.1 GenOway Company Details
        7.7.2 GenOway Business Overview
        7.7.3 GenOway Humanized Immune System (HIS) Models Introduction
        7.7.4 GenOway Revenue in Humanized Immune System (HIS) Models Business (2021-2026)
        7.7.5 GenOway Recent Development
    7.8 Oncodesign Services
        7.8.1 Oncodesign Services Company Details
        7.8.2 Oncodesign Services Business Overview
        7.8.3 Oncodesign Services Humanized Immune System (HIS) Models Introduction
        7.8.4 Oncodesign Services Revenue in Humanized Immune System (HIS) Models Business (2021-2026)
        7.8.5 Oncodesign Services Recent Development
    7.9 Champions Oncology
        7.9.1 Champions Oncology Company Details
        7.9.2 Champions Oncology Business Overview
        7.9.3 Champions Oncology Humanized Immune System (HIS) Models Introduction
        7.9.4 Champions Oncology Revenue in Humanized Immune System (HIS) Models Business (2021-2026)
        7.9.5 Champions Oncology Recent Development
    7.10 Miltenyi Biotec
        7.10.1 Miltenyi Biotec Company Details
        7.10.2 Miltenyi Biotec Business Overview
        7.10.3 Miltenyi Biotec Humanized Immune System (HIS) Models Introduction
        7.10.4 Miltenyi Biotec Revenue in Humanized Immune System (HIS) Models Business (2021-2026)
        7.10.5 Miltenyi Biotec Recent Development
    7.11 BioDuro
        7.11.1 BioDuro Company Details
        7.11.2 BioDuro Business Overview
        7.11.3 BioDuro Humanized Immune System (HIS) Models Introduction
        7.11.4 BioDuro Revenue in Humanized Immune System (HIS) Models Business (2021-2026)
        7.11.5 BioDuro Recent Development
    7.12 GemPharmatech
        7.12.1 GemPharmatech Company Details
        7.12.2 GemPharmatech Business Overview
        7.12.3 GemPharmatech Humanized Immune System (HIS) Models Introduction
        7.12.4 GemPharmatech Revenue in Humanized Immune System (HIS) Models Business (2021-2026)
        7.12.5 GemPharmatech Recent Development
    7.13 Shanghai Model Organisms
        7.13.1 Shanghai Model Organisms Company Details
        7.13.2 Shanghai Model Organisms Business Overview
        7.13.3 Shanghai Model Organisms Humanized Immune System (HIS) Models Introduction
        7.13.4 Shanghai Model Organisms Revenue in Humanized Immune System (HIS) Models Business (2021-2026)
        7.13.5 Shanghai Model Organisms Recent Development
    7.14 Biocytogen
        7.14.1 Biocytogen Company Details
        7.14.2 Biocytogen Business Overview
        7.14.3 Biocytogen Humanized Immune System (HIS) Models Introduction
        7.14.4 Biocytogen Revenue in Humanized Immune System (HIS) Models Business (2021-2026)
        7.14.5 Biocytogen Recent Development

8 Humanized Immune System (HIS) Models Market Dynamics
    8.1 Humanized Immune System (HIS) Models Industry Trends
    8.2 Humanized Immune System (HIS) Models Market Drivers
    8.3 Humanized Immune System (HIS) Models Market Challenges
    8.4 Humanized Immune System (HIS) Models Market Restraints

9 Research Findings and Conclusion

10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Humanized Immune System (HIS) Models Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Global Humanized Immune System (HIS) Models Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 3. Global Market Humanized Immune System (HIS) Models Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
 Table 4. Global Humanized Immune System (HIS) Models Revenue (US$ Million) Market Share by Region (2021-2026)
 Table 5. Global Humanized Immune System (HIS) Models Revenue Share by Region (2021-2026)
 Table 6. Global Humanized Immune System (HIS) Models Revenue (US$ Million) Forecast by Region (2027-2032)
 Table 7. Global Humanized Immune System (HIS) Models Revenue Share Forecast by Region (2027-2032)
 Table 8. Global Humanized Immune System (HIS) Models Market Size by Type (2021-2026) & (US$ Million)
 Table 9. Global Humanized Immune System (HIS) Models Market Share by Revenue, by Type (2021-2026)
 Table 10. Global Humanized Immune System (HIS) Models Forecasted Market Size by Type (2027-2032) & (US$ Million)
 Table 11. Global Humanized Immune System (HIS) Models Market Share by Revenue, by Type (2027-2032)
 Table 12. Representative Players of Each Type
 Table 13. Global Humanized Immune System (HIS) Models Market Size by Application (2021-2026) & (US$ Million)
 Table 14. Global Humanized Immune System (HIS) Models Market Share by Revenue, by Application (2021-2026)
 Table 15. Global Humanized Immune System (HIS) Models Forecasted Market Size by Application (2027-2032) & (US$ Million)
 Table 16. Global Humanized Immune System (HIS) Models Market Share by Revenue, by Application (2027-2032)
 Table 17. New Sources of Growth in Humanized Immune System (HIS) Models Applications
 Table 18. Global Humanized Immune System (HIS) Models Revenue by Players (2021-2026) & (US$ Million)
 Table 19. Global Humanized Immune System (HIS) Models Market Share by Players (2021-2026)
 Table 20. Global Top Humanized Immune System (HIS) Models Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Humanized Immune System (HIS) Models as of 2025)
 Table 21. Ranking of Global Top Humanized Immune System (HIS) Models Companies by Revenue (US$ Million) in 2025
 Table 22. Global 5 Largest Players Market Share by Humanized Immune System (HIS) Models Revenue (CR5 and HHI) & (2021-2026)
 Table 23. Global Key Players of Humanized Immune System (HIS) Models, Headquarters and Area Served
 Table 24. Global Key Players of Humanized Immune System (HIS) Models, Product and Application
 Table 25. Global Key Players of Humanized Immune System (HIS) Models, Date of Entry into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. North America Humanized Immune System (HIS) Models Revenue by Company (2021-2026) & (US$ Million)
 Table 28. North America Humanized Immune System (HIS) Models Market Share by Revenue, by Company (2021-2026)
 Table 29. North America Humanized Immune System (HIS) Models Market Size by Type (2021-2026) & (US$ Million)
 Table 30. North America Humanized Immune System (HIS) Models Market Size by Application (2021-2026) & (US$ Million)
 Table 31. Europe Humanized Immune System (HIS) Models Revenue by Company (2021-2026) & (US$ Million)
 Table 32. Europe Humanized Immune System (HIS) Models Market Share by Revenue, by Company (2021-2026)
 Table 33. Europe Humanized Immune System (HIS) Models Market Size by Type (2021-2026) & (US$ Million)
 Table 34. Europe Humanized Immune System (HIS) Models Market Size by Application (2021-2026) & (US$ Million)
 Table 35. China Humanized Immune System (HIS) Models Revenue by Company (2021-2026) & (US$ Million)
 Table 36. China Humanized Immune System (HIS) Models Market Share by Revenue, by Company (2021-2026)
 Table 37. China Humanized Immune System (HIS) Models Market Size by Type (2021-2026) & (US$ Million)
 Table 38. China Humanized Immune System (HIS) Models Market Size by Application (2021-2026) & (US$ Million)
 Table 39. Japan Humanized Immune System (HIS) Models Revenue by Company (2021-2026) & (US$ Million)
 Table 40. Japan Humanized Immune System (HIS) Models Market Share by Revenue, by Company (2021-2026)
 Table 41. Japan Humanized Immune System (HIS) Models Market Size by Type (2021-2026) & (US$ Million)
 Table 42. Japan Humanized Immune System (HIS) Models Market Size by Application (2021-2026) & (US$ Million)
 Table 43. Charles River Company Details
 Table 44. Charles River Business Overview
 Table 45. Charles River Humanized Immune System (HIS) Models Product
 Table 46. Charles River Revenue in Humanized Immune System (HIS) Models Business (2021-2026) & (US$ Million)
 Table 47. Charles River Recent Development
 Table 48. Taconic Biosciences Company Details
 Table 49. Taconic Biosciences Business Overview
 Table 50. Taconic Biosciences Humanized Immune System (HIS) Models Product
 Table 51. Taconic Biosciences Revenue in Humanized Immune System (HIS) Models Business (2021-2026) & (US$ Million)
 Table 52. Taconic Biosciences Recent Development
 Table 53. Inotiv Company Details
 Table 54. Inotiv Business Overview
 Table 55. Inotiv Humanized Immune System (HIS) Models Product
 Table 56. Inotiv Revenue in Humanized Immune System (HIS) Models Business (2021-2026) & (US$ Million)
 Table 57. Inotiv Recent Development
 Table 58. Jackson Laboratory Company Details
 Table 59. Jackson Laboratory Business Overview
 Table 60. Jackson Laboratory Humanized Immune System (HIS) Models Product
 Table 61. Jackson Laboratory Revenue in Humanized Immune System (HIS) Models Business (2021-2026) & (US$ Million)
 Table 62. Jackson Laboratory Recent Development
 Table 63. Janvier Company Details
 Table 64. Janvier Business Overview
 Table 65. Janvier Humanized Immune System (HIS) Models Product
 Table 66. Janvier Revenue in Humanized Immune System (HIS) Models Business (2021-2026) & (US$ Million)
 Table 67. Janvier Recent Development
 Table 68. Crown Bioscience Company Details
 Table 69. Crown Bioscience Business Overview
 Table 70. Crown Bioscience Humanized Immune System (HIS) Models Product
 Table 71. Crown Bioscience Revenue in Humanized Immune System (HIS) Models Business (2021-2026) & (US$ Million)
 Table 72. Crown Bioscience Recent Development
 Table 73. GenOway Company Details
 Table 74. GenOway Business Overview
 Table 75. GenOway Humanized Immune System (HIS) Models Product
 Table 76. GenOway Revenue in Humanized Immune System (HIS) Models Business (2021-2026) & (US$ Million)
 Table 77. GenOway Recent Development
 Table 78. Oncodesign Services Company Details
 Table 79. Oncodesign Services Business Overview
 Table 80. Oncodesign Services Humanized Immune System (HIS) Models Product
 Table 81. Oncodesign Services Revenue in Humanized Immune System (HIS) Models Business (2021-2026) & (US$ Million)
 Table 82. Oncodesign Services Recent Development
 Table 83. Champions Oncology Company Details
 Table 84. Champions Oncology Business Overview
 Table 85. Champions Oncology Humanized Immune System (HIS) Models Product
 Table 86. Champions Oncology Revenue in Humanized Immune System (HIS) Models Business (2021-2026) & (US$ Million)
 Table 87. Champions Oncology Recent Development
 Table 88. Miltenyi Biotec Company Details
 Table 89. Miltenyi Biotec Business Overview
 Table 90. Miltenyi Biotec Humanized Immune System (HIS) Models Product
 Table 91. Miltenyi Biotec Revenue in Humanized Immune System (HIS) Models Business (2021-2026) & (US$ Million)
 Table 92. Miltenyi Biotec Recent Development
 Table 93. BioDuro Company Details
 Table 94. BioDuro Business Overview
 Table 95. BioDuro Humanized Immune System (HIS) Models Product
 Table 96. BioDuro Revenue in Humanized Immune System (HIS) Models Business (2021-2026) & (US$ Million)
 Table 97. BioDuro Recent Development
 Table 98. GemPharmatech Company Details
 Table 99. GemPharmatech Business Overview
 Table 100. GemPharmatech Humanized Immune System (HIS) Models Product
 Table 101. GemPharmatech Revenue in Humanized Immune System (HIS) Models Business (2021-2026) & (US$ Million)
 Table 102. GemPharmatech Recent Development
 Table 103. Shanghai Model Organisms Company Details
 Table 104. Shanghai Model Organisms Business Overview
 Table 105. Shanghai Model Organisms Humanized Immune System (HIS) Models Product
 Table 106. Shanghai Model Organisms Revenue in Humanized Immune System (HIS) Models Business (2021-2026) & (US$ Million)
 Table 107. Shanghai Model Organisms Recent Development
 Table 108. Biocytogen Company Details
 Table 109. Biocytogen Business Overview
 Table 110. Biocytogen Humanized Immune System (HIS) Models Product
 Table 111. Biocytogen Revenue in Humanized Immune System (HIS) Models Business (2021-2026) & (US$ Million)
 Table 112. Biocytogen Recent Development
 Table 113. Humanized Immune System (HIS) Models Market Trends
 Table 114. Humanized Immune System (HIS) Models Market Drivers
 Table 115. Humanized Immune System (HIS) Models Market Challenges
 Table 116. Humanized Immune System (HIS) Models Market Restraints
 Table 117. Research Programs/Design for This Report
 Table 118. Key Data Information from Secondary Sources
 Table 119. Key Data Information from Primary Sources


List of Figures
 Figure 1. Humanized Immune System (HIS) Models Product Picture
 Figure 2. Global Humanized Immune System (HIS) Models Market Share by Type: 2025 vs 2032
 Figure 3. Mouse Features
 Figure 4. Rat Features
 Figure 5. Global Humanized Immune System (HIS) Models Market Share by Application: 2025 vs 2032
 Figure 6. Research Institutes
 Figure 7. Pharmaceutical Companies
 Figure 8. Humanized Immune System (HIS) Models Report Years Considered
 Figure 9. Global Humanized Immune System (HIS) Models Market Size (US$ Million), Year-over-Year: 2021-2032
 Figure 10. Global Humanized Immune System (HIS) Models Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Humanized Immune System (HIS) Models Market Share by Revenue, by Region: 2021 vs 2025
 Figure 12. North America Humanized Immune System (HIS) Models Revenue (US$ Million) Growth Rate (2021-2032)
 Figure 13. Europe Humanized Immune System (HIS) Models Revenue (US$ Million) Growth Rate (2021-2032)
 Figure 14. China Humanized Immune System (HIS) Models Revenue (US$ Million) Growth Rate (2021-2032)
 Figure 15. Japan Humanized Immune System (HIS) Models Revenue (US$ Million) Growth Rate (2021-2032)
 Figure 16. Global Humanized Immune System (HIS) Models Market Share by Players in 2025
 Figure 17. Global Top Humanized Immune System (HIS) Models Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Humanized Immune System (HIS) Models as of 2025)
 Figure 18. The Top 10 and 5 Players Market Share by Humanized Immune System (HIS) Models Revenue in 2025
 Figure 19. North America Humanized Immune System (HIS) Models Market Share by Type (2021-2026)
 Figure 20. North America Humanized Immune System (HIS) Models Market Share by Application (2021-2026)
 Figure 21. Europe Humanized Immune System (HIS) Models Market Share by Type (2021-2026)
 Figure 22. Europe Humanized Immune System (HIS) Models Market Share by Application (2021-2026)
 Figure 23. China Humanized Immune System (HIS) Models Market Share by Type (2021-2026)
 Figure 24. China Humanized Immune System (HIS) Models Market Share by Application (2021-2026)
 Figure 25. Japan Humanized Immune System (HIS) Models Market Share by Type (2021-2026)
 Figure 26. Japan Humanized Immune System (HIS) Models Market Share by Application (2021-2026)
 Figure 27. Charles River Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2021-2026)
 Figure 28. Taconic Biosciences Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2021-2026)
 Figure 29. Inotiv Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2021-2026)
 Figure 30. Jackson Laboratory Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2021-2026)
 Figure 31. Janvier Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2021-2026)
 Figure 32. Crown Bioscience Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2021-2026)
 Figure 33. GenOway Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2021-2026)
 Figure 34. Oncodesign Services Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2021-2026)
 Figure 35. Champions Oncology Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2021-2026)
 Figure 36. Miltenyi Biotec Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2021-2026)
 Figure 37. BioDuro Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2021-2026)
 Figure 38. GemPharmatech Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2021-2026)
 Figure 39. Shanghai Model Organisms Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2021-2026)
 Figure 40. Biocytogen Revenue Growth Rate in Humanized Immune System (HIS) Models Business (2021-2026)
 Figure 41. Bottom-up and Top-down Approaches for This Report
 Figure 42. Data Triangulation
 Figure 43. Key Executives Interviewed

Description

The global Humanized Immune System (HIS) Models market size was US$ 268 million in 2025 and is forecast to reach a readjusted size of US$ 433 million by 2032 with a CAGR of 7.2% during the forecast period 2026-2032.

Humanized Immune System (HIS) models are animal models, typically immunodeficient mice, engrafted with human immune cells or hematopoietic stem cells to reconstitute a functional human immune system. These models allow the study of human-specific immune responses and are widely used in research on infectious diseases, cancer immunology, autoimmune disorders, and immunotherapy development. HIS models provide a crucial platform for preclinical testing and translational medicine.

In 2025, the North America Humanized Immune System (HIS) Models market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.

The global key players of Humanized Immune System (HIS) Models include Charles River, Taconic Biosciences, Inotiv, Jackson Laboratory, Janvier, Crown Bioscience, GenOway, Oncodesign Services, Champions Oncology, Miltenyi Biotec, among others. In 2025, the top five players accounted for approximately % of global market revenue.

In terms of revenue, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.

The global Humanized Immune System (HIS) Models market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.

Market Segmentation
By Company: 
    Charles River
    Taconic Biosciences
    Inotiv
    Jackson Laboratory
    Janvier
    Crown Bioscience
    GenOway
    Oncodesign Services
    Champions Oncology
    Miltenyi Biotec
    BioDuro
    GemPharmatech
    Shanghai Model Organisms
    Biocytogen

Segment by Type
    Mouse
    Rat

Segment by Application
    Research Institutes
    Pharmaceutical Companies

By Region 
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
    North America
    Europe
    China
    Japan

(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of Humanized Immune System (HIS) Models market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets 
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities 
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Humanized Immune System (HIS) Models value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

undefined

Related Reports

Global Humanized Immune System (HIS) Models Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Humanized Immune System (HIS) Models market size was US$ 247 million in 2024 and is forecast to a readjusted size of US$ 407 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published: 2025-08-03
Pages: 96
USD 4250.00
(Single User License)
Humanized Immune System (HIS) Models - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Humanized Immune System (HIS) Models was estimated to be worth US$ 247 million in 2024 and is forecast to a readjusted size of US$ 407 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published: 2025-08-03
Pages: 104
USD 3950.00
(Single User License)
Global Humanized Immune System (HIS) Models Market Research Report 2025
The global market for Humanized Immune System (HIS) Models was valued at US$ 247 million in the year 2024 and is projected to reach a revised size of US$ 407 million by 2031, growing at a CAGR of 7.2% during the forecast period.
Published: 2025-08-03
Pages: 84
USD 2900.00
(Single User License)
Global Humanized Immune System (HIS) Models Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Humanized Immune System (HIS) Models market is projected to grow from US$ 247 million in 2024 to US$ 407 million by 2031, at a CAGR of 7.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-03
Pages: 134
USD 4900.00
(Single User License)
Humanized Immune System (HIS) Models - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Humanized Immune System (HIS) Models was estimated to be worth US$ 268 million in 2025 and is projected to reach US$ 433 million, growing at a CAGR of 7.2% from 2026 to 2032.
Published: 2026-03-09
Pages: 108
USD 3950.00
(Single User License)
Global Humanized Immune System (HIS) Models Market Research Report 2026
The global Humanized Immune System (HIS) Models market was valued at US$ 268 million in 2025 and is anticipated to reach US$ 433 million by 2032, at a CAGR of 7.2% from 2026 to 2032.
Published: 2026-03-12
Pages: 111
USD 2900.00
(Single User License)
Global Humanized Immune System (HIS) Models Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Humanized Immune System (HIS) Models market is projected to grow from US$ 268 million in 2025 to US$ 433 million by 2032, at a CAGR of 7.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-12
Pages: 135
USD 4900.00
(Single User License)

Global Humanized Immune System (HIS) Models Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Humanized Immune System (HIS) Models market size was US$ 247 million in 2024 and is forecast to a readjusted size of US$ 407 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published: 2025-08-03
Pages: 96
USD 4250.00 (Single User License)
Humanized Immune System (HIS) Models - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Humanized Immune System (HIS) Models was estimated to be worth US$ 247 million in 2024 and is forecast to a readjusted size of US$ 407 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published: 2025-08-03
Pages: 104
USD 3950.00 (Single User License)
Global Humanized Immune System (HIS) Models Market Research Report 2025
The global market for Humanized Immune System (HIS) Models was valued at US$ 247 million in the year 2024 and is projected to reach a revised size of US$ 407 million by 2031, growing at a CAGR of 7.2% during the forecast period.
Published: 2025-08-03
Pages: 84
USD 2900.00 (Single User License)
Global Humanized Immune System (HIS) Models Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Humanized Immune System (HIS) Models market is projected to grow from US$ 247 million in 2024 to US$ 407 million by 2031, at a CAGR of 7.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-03
Pages: 134
USD 4900.00 (Single User License)
Humanized Immune System (HIS) Models - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Humanized Immune System (HIS) Models was estimated to be worth US$ 268 million in 2025 and is projected to reach US$ 433 million, growing at a CAGR of 7.2% from 2026 to 2032.
Published: 2026-03-09
Pages: 108
USD 3950.00 (Single User License)
Global Humanized Immune System (HIS) Models Market Research Report 2026
The global Humanized Immune System (HIS) Models market was valued at US$ 268 million in 2025 and is anticipated to reach US$ 433 million by 2032, at a CAGR of 7.2% from 2026 to 2032.
Published: 2026-03-12
Pages: 111
USD 2900.00 (Single User License)
Global Humanized Immune System (HIS) Models Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Humanized Immune System (HIS) Models market is projected to grow from US$ 268 million in 2025 to US$ 433 million by 2032, at a CAGR of 7.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-12
Pages: 135
USD 4900.00 (Single User License)